Detalle Publicación

EDITORIAL

When Cancer Vaccines Go Viral

Autores: Repáraz Pernaut, David; Llopiz Khatchikian, Diana Isabel; Sarobe Ugarriza, Pablo (Autor de correspondencia)
Título de la revista: CLINICAL CANCER RESEARCH
ISSN: 1078-0432
Volumen: 25
Número: 16
Páginas: 4871 - 4873
Fecha de publicación: 2019
Resumen:
Induction of antitumor responses by vaccines requires strong immunogens. Heterologous viral prime/boost immunization with the BN-CV301 vaccine promotes activation of immune responses that provide a clinical benefit to patients with cancer. This viral platform may be used to harbor different antigens and prime tumor immunity potentially useful for combinatorial strategies.
DOI: https://doi.org/10.1158/1078-0432.CCR-19-1652
Impacto:
Google Scholar